The effects of regular home delivery of HIV self-testing and follow-up counselling on HIV testing and prevention outcomes in men who have sex with men who test infrequently in the United States: a pragmatic, virtual randomized controlled trial

The effects of regular home delivery of HIV self-testing and follow-up counselling on HIV testing and prevention outcomes in men who have sex with men who test infrequently in the United States: a pragmatic, virtual randomized controlled trial

J Int AIDS Soc. 2024 Jul;27(7):e26318. doi: 10.1002/jia2.26318.

INTRODUCTION: Research has shown that HIV self-testing (HIVST) can lead to increased testing and more HIV diagnoses compared to clinic testing. However, concerns in the United States about HIVST users being less likely to seek care have limited its use.

METHODS: From January 2019 to April 2022, 811 men who have sex with men (MSM) in the United States, who infrequently tested, were recruited through an online campaign. They were randomly assigned to receive one of the following every 3 months for a year: (1) text message reminders for clinic testing (control); (2) mailed HIVST kits with access to a helpline (standard HIVST); and (3) mailed HIVST kits with counselling within 24 hours of opening a kit (eTest). Follow-up surveys assessed HIV testing, sexually transmitted infection (STI) testing, pre-exposure prophylaxis (PrEP) use, and sexual risk behavior.

FINDINGS: Eight participants were diagnosed with HIV, mostly through HIVST. Participants in both HIVST groups had significantly higher odds of testing and repeat testing over 12 months compared to the control group. Rates of STI testing and PrEP uptake did not differ, but those in the eTest group reported fewer sexual risk events.

CONCLUSIONS: HIVST greatly increased testing, promoted more regular testing among MSM, and identified nearly all new cases, suggesting earlier diagnosis of HIV acquisition. Follow-up counselling after HIVST did not increase STI testing or PrEP use, but may have reduced sexual risk behavior. To encourage more optimal testing, programs should incorporate HIVST and regularly ship kits to recipients.

PMID: 39020453 | DOI: 10.1002/jia2.26318

Clinical trials are essential for developing safe and effective treatments. It’s important to extend their benefits into everyday medical practice. DocSym, our AI-driven platform, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians.

In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.

By using AI, clinics can enhance their workflows and improve patient outcomes, reducing paper routines. Learn more about how we can help at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.